Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02711
Species: Homo sapiens
Position : chr1:42614062-42616745
Year: 2022
Title: A 汕-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: colorectal cancer
PMID:  34954189
MONDO: MONDO:0005575
Tissue: colon
Tissue Ontology ID: UBERON:0001155
Cell Source: HCT 116
CVCL ID: CVCL_0291
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, Functional perturbation assay; Enhancer activity assay; Endogenous enhancer perturbation; Chromatin-state profiling
High Throughput Method: ChIP-seq, RNA-seq; RNA-seq; ChIP-seq
Low Throughput Method: Luciferase Reporter Assay, CRISPR Knockout, CRISPRi, CRISPRa, ChIP-RT-qPCR, RT-RT-qPCR; CRISPR-Cas9 endogenous deletion/editing; Luciferase reporter assay; ChIP
About Target Gene
Target gene : GUCA2A
About TF
TF name : NA
About Regulatory State
Regulatory State : Repressed
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_02716 chr1:42614062-42616745 bone marrow malignant cell acute myeloid leukemia
Expression of Target Genes for the Enhancer